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ABSTRACT
We have recently shown that Matrigel-filled chambers containing fibroblast growth factor-2 (FGF2) and
placed around an epigastric pedicle in the mouse were highly adipogenic. Contact of this construct with
pre-existing tissue or a free adipose graft was required. To further investigate the mechanisms under-
pinning formation of new adipose tissue, we seeded these chambers with human adipose biopsies and
human adipose-derived cell populations in severe combined immunodeficient mice and assessed the
origin of the resultant adipose tissue after 6 weeks using species-specific probes. The tissues were negative
for human-specific vimentin labeling, suggesting that the fat originates from the murine host rather than
the human graft. This was supported by the strong presence of mouse-specific Cot-1 deoxyribonucleic
acid labeling, and the absence of human Cot-1 labeling in the new fat. Even chambers seeded with FGF2/
Matrigel containing cultured human stromal-vascular fraction (SVF) labeled strongly only for human
vimentin in cells that did not have a mature adipocyte phenotype; the newly formed fat tissue was neg-
ative for human vimentin. These findings indicate that grafts placed in the chamber have an inductive
function for neo-adipogenesis, rather than supplying adipocyte-precursor cells to generate the new fat
tissue, and preliminary observations implicate the SVF in producing inductive factors. This surprising
finding opens the door for refinement of current adipose tissue–engineering approaches.
INTRODUCTION
ADIPOSE-TISSUE ENGINEERING OFFERS improved treatmentoptions in clinical practice by providing autologous tis-
sue to restore tissue volume and surface contour. Successful
tissue fabrication must include an appropriate environment
for cell viability and function at the microscale level, as well
as providing macroscale-level properties that allow sufficient
transport of nutrients, provide adequate mechanical proper-
ties and tissue expansion, and facilitate coordination ofmulti-
cellular processes.1 The new tissue construct should prosper
in equilibrium through biochemical, structural, and cellular
cues and approximate the morphology and function of the
native tissue equivalent.
Free-fat grafting rarely achieves sufficient tissue augmen-
tation because of delayed neo-vascularization with subse-
quent cell necrosis, fibrosis, and graft volume shrinkage. It
succeedsat amicroscale level byproviding the appropriate cell
type in a suitable environment but fails at a macroscale level,
because the majority of the transplanted cells become located
more than 100mm away from blood vessels in the residual tis-
sue, which is the diffusion limit for oxygen. The absence of
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more-suitable alternatives, such as tissue-engineering ap-
proaches, has led to its continued use despite variable resorp-
tion and lipid cyst formation.
A de novo engineered adipose tissue construct may be
accomplished in vivo at the recipient site or cultured in vivo
or in vitro. Hausberger found that new adipose tissue was
deposited when grafts were transplanted in a newborn rat
model.2 However, developing cells need an instructive ma-
trix, and in natural tissues, the extracellular matrix (ECM)
is known to provide structural stability, to orient and con-
strain cells during regeneration, and to act as a preserver of
space for the new cells to develop.3 The ECM is actively
remodeled during adipogenesis, with its geometrical archi-
tecture being an environmental cue for adipose tissue for-
mation,3,4
Recent experimental models have used progenitor cells
seeded onto ECMs or scaffolds in vitro, which are then im-
planted in vivo to generate bioartificial fat constructs. This
strategy, called histioconduction,5–10 works on the premise
that the 3-dimensional (3-D) scaffolds direct cell prolifera-
tion, differentiation, and organization into multicellular com-
munities in such a way as a biohybrid, approximating the
in vivo microarchitecture of functional subunits (*100mm),
the local microenvironment around cells (*10 mm), and the
function of the wanted tissue,11 is produced. In practice,
this approach is successful for the production of small vol-
umes of tissue but has little clinical utility. The simple ad-
dition of cells to biocompatible scaffolds is inadequate for
reproducing the biological and functional characteristics of
the wanted tissue and fails to address the problem of vas-
cularization of the biohybrid upon implantation, which sig-
nificantly limits the size of the construct (and its clinical
utility). This is especially true for tissues with a high met-
abolic demand, and tissue-engineering solutions might be
more difficult to achieve for adipose tissue, which is strongly
dependent on a functional vascular network.
An alternative for engineering adipose tissue constructs in-
volves the induction of neovascularization of a cell–matrix
scaffold, with concomitant recruitment of resident stem cells
for the production of the target tissue (histioinduction). One
matrix scaffold that has proven useful for experimental adi-
pogenic histioinduction is Matrigel.12,13 Kawaguchi demon-
strated that subcutaneously injected Matrigel supplemented
with FGF2 (at a dose of 1mg/mL Matrigel) induced de novo
adipogenesis in mice.12 Angiogenic induction combined with
the structural support provided by the Matrigel matrix ap-
peared to create an ideal microenvironment for endogenous
preadipocytes to migrate, proliferate, and differentiate.14 The
stromal-vascular fraction (SVF) of adipose tissue is a well-
known source of multipotent adult stem cells and the pre-
sumed source of the recruited preadipocytes.15 Similarly, we
found that Matrigel combined with FGF2 induced de novo
angiogenesis and adipogenesis in a murine epigastric cham-
ber model.16
Changes in the chamber configuration led to the obser-
vation that contact with existing fat tissue was essential for
the adipogenic response to Matrigel to occur.17 The ob-
servation that chambers without access to any fat generated
little or no adipose tissue, whereas the inclusion of an ad-
ipose graft within the sealed chamber with Matrigel gave
reliable adipogenesis strengthened this hypothesis. We hy-
pothesized that the addition of fat grafts to the sealed mouse
chamber provided an adipogenic precursor cell source that
combines with the Matrigel in the chamber to produce fat.
To test this hypothesis, we added human adipose tissue (do-
nor) to the chamber model using severe combined immu-
nodeficient (SCID) mice (host) and used species-specific
probes to determine whether the newly formed fat was of
host or donor origin. We found clear evidence of host rather
than graft origin, indicating that the Matrigel/FGF2-filled
chamber, in conjunction with factors provided by the preex-
isting adipose tissue, recruits endogenous precursor cells that
ultimately differentiate into new adipose tissue. This is an
important refinement, given the popularity of adipose tissue
grafting and the expectation that the adipose tissue grafts
would contribute precursor cells.
MATERIALS AND METHODS
The St. Vincent’s Hospital Animal Ethics Committee ap-
proved All animal experiments, which were conducted in
accordance with the National Health and Medical Research
Council (Australia) guidelines. Twelve-week-old SCIDmice
(minimum weight 18 g, ARC, Perth, Australia) were used in
this study and maintained in Techniplast individually ven-
tilated cages (Milan, Italy) with standard chow and water
ad libitum.
Materials
Cylindrical chambers were fashioned from 5-mm lengths
of laboratory tubing (Dow-Corning Corp., Midland, MI),
with an internal diameter of 3.35mm and a volume of 44 mL,
as previously described.16,17 Dulbecco’s modified Eagles
medium (DMEM), penicillin G, and streptomycin sulfate
were purchased from Gibco/Invitrogen Life Technologies
Corporation (GlenWaverley, Australia). Phosphate buffered
saline (PBS) solution was purchased from Oxoid Ltd.
(Hampshire, England). Trypsin and fetal calf serum (FCS)
were purchased from CSL Ltd. (Melbourne, Australia).
Matrigel (complete Matrigel unless specified as growth
factor reduced (GFR)) was obtained from Becton & Dick-
inson (North Ryde, Australia).
Fat graft preparation
Human adipose biopsies were obtained with informed
preoperative patient consent through the Plastic and Recon-
structive Surgery Unit at St Vincent’s Hospital, Melbourne,
with approval from the St Vincent’s Hospital Human Re-
search Ethics Committee. Specimens were obtained from the
abdominal region during reconstructive surgery and trans-
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ported on ice in DMEM. Excess fibrous tissue was dissected
under aseptic conditions, and specimens were randomly
minced into small cubes of 1 to 3mm3 before being washed
twice in fresh DMEM. The selected cubes were then sealed
separately in preweighed Eppendorf tubes containing
DMEM and kept on ice until implantation. The weight of
each specimen was recorded before implantation.
Matrigel-enriched cell cultures
Forty-eight-well tissue culture plates (Becton & Dickin-
son) were coated with GFR Matrigel supplemented with
1 mg/mL FGF2 (Sigma Aldrich, Sydney, Australia) and
80U/mL of unfractionated sodium heparin (APP Inc,
Schaumburg, IL) and allowed to set at 378C for 2 to 3min.
Tissue cubes 2 to 3mm3 in size were dissected from crude
fat biopsies, assessed for degree of SVF content, and placed
onto the Matrigel-coated wells before gelation, and the
whole plate was incubated for 2 to 3 minutes at 378C. The
wells were then filled with 0.5mL of DMEM supplemen-
ted with 10% FCS, 2.92 mg/mL L-glutamine, and 100 m/mL
penicillin G/streptomycin sulfate and the plates incubated at
378C in a humidified, 5% carbon dioxide (CO2) atmosphere
for 4 to 8 weeks. Medium was changed every 3 to 4 days.
These are refereed to as MA cultures.
SVF culture
Large fibrous tissues were carefully dissected from the
fat biopsy. The remaining tissue was digested with 0.2%
collagenase (Type I, Worthington Pty Ltd., Lakewood, NJ)
in PBS with shaking at 378C. Large tissue chunks were
removed using a 100-mm cell strainer. Samples were pelleted
in a standard cell culture centrifuge at room temperature and
washed 3 times with PBS. Cell pellets were resuspended in
DMEM with 10% FCS and antibiotics as described above.
After counting, cells were plated into tissue culture flasks at
approximately 2.1106 cells per 75-cm2 flask. Cultures were
then incubated at 378C 5% CO2. Non-adherent red blood
cells were removed with 3 PBS washes on the following day.
The resultant SVFwas cultivated and used within 3 passages.
The flow-through loop pedicle murine chamber model
The in vivo model used was essentially as previously de-
scribed.16,17 Briefly, the mice were anesthetized with an
intraperitoneal injection of chloral hydrate (0.4mg/g body
weight), and the groin and upper legs were depilated. Silicon
chambers were inserted bilaterally in both groins, with the
superficial inferior epigastric vessels being dissected free
from the surrounding tissue, and then encased by the cham-
ber, which was opened along one side to allow incorpora-
tion of the vessels. The chamber was sealed at the femoral
end and along the lateral split with melted Ethicon bone
wax ( Johnson & Johnson International, St Stevens-Woluwe,
Belgium). The entire chamber was then anchored to the
underlying muscle with a 10/0 nylon suture (Davis & Geck,
St Louis, MO) to prevent dislodgement during postoperative
mobilization of the animals. The chamber was then filled
with Matrigel, the fat biopsy or cells were placed in the
Matrigel, and the epididymal end was sealed with melted
bone wax, avoiding any excessive heating or obstruction
of the vascular pedicle. Skin incisions were closed with
surgical clips.
Harvest of tissue
There were 5 experimental groups (A–E), all containing
Matrigel and all harvested at 6 weeks postimplantation, ex-
cept group B (9-week harvest). Groups A (n¼ 13 chambers)
and B (n¼ 8 chambers) contained human adipose tissue
autografts, Group C (n¼ 15 chambers) had established MA
cultures (with or without original fat biopsies) added to the
chambers instead of fat biopsies, Group D (n¼ 6 chambers)
had SVF culture rather than biopsy added to the chamber,
and Group E (n¼ 8 chambers) were Matrigel-only controls.
Chambers were removed under aseptic conditions at 6 or 9
weeks postimplantation under the same anesthetic condi-
tions used for chamber insertion, and the mice were then
killed using a lethal intraperitoneal dose of 0.3mL of Le-
thobarb (Pentobarbitone, Virbac, NSW, Australia). During
chamber removal, the patency of the vascular pedicle was
assessed by looking for evidence of bleeding from the ves-
sel ends when the pedicles were cut where they exited the
chamber. The chamber could then be removed from its
surrounding capsule and its contents assessed. Chamber tis-
sues were all weighed and measured using standard volume-
displacement techniques. Specimens were fixed overnight
in 10% buffered formalin, dehydrated, and embedded in
paraffin wax in the standard manner.
Morphological analysis
Samples were cut into 5-mm sections, mounted onto slides,
and stained with Masson’s Trichrome to assist with identifi-
cationofadipose tissue (mature adipocytes), connective tissue,
angiogenesis (endothelial cells/new blood vessels), biopsy
(original cells from the fat biopsy), vascular pedicle, and
remnants of Matrigel in the sections using point counting.
Every 20th section throughout each specimen was point
counted, as previously described,16,17 using the Computer
Assisted Stereological ToolBox system (Olympus Denmark
A/S, Albertsland, Denmark). The adipose tissue percentage of
each specimen was determined dividing the number of points
containing adipose tissue by the total number of points con-
taining tissue, and multiplying by 100.
Vimentin immunolocalization
Immunolabeling of human vimentin in these sections was
performed using the Dako ARK (Animal Research Kit, Dako,
Carpinteria, CA). Sections were dewaxed, rehydrated, incu-
bated in Dako target retrieval buffer (pH 6.0) at 958C for
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20min, and then left to cool at room temperature for the same
time. All subsequent steps took place at room temperature,
and washes between steps were performed with PBS. Endo-
genous peroxidase activity was quenched with 3% hydrogen
peroxide for 5min, the primary antibody (Dako mouse anti-
vimentin, clone V9) was biotinylated according to kit in-
structions, and 100 mL was applied to sections at 1:600 for
30min. Sections were then incubated with streptavidin-
peroxidase for 30min, followed by 3,3-diaminobenzidine
chromogen solution (Dako) for 5min. They were then
counterstained with Mayer’s hematoxylin, dehydrated, and
mounted in Depex (BDH Chemicals, Kilsyth, Australia).
Confirmation of vimentin reactivity in mouse cells was per-
formed using a second vimentin antibody (Abcam rabbit
anti-vimentin, ab7783). Dewaxing, hydration, antigen re-
trieval, and peroxidase quenching were performed as de-
scribed above. Non-specific binding was blocked using 10%
normal swine serum (Dako) and the primary antibody diluted
1:300 in buffer with 1% bovine serum albumin then applied.
This was followed with swine anti-rabbit biotin (Dako),
1:400 for 30min; horseradish peroxidase–streptavidin (Dako),
1:400 for 30min; and 3,3-diaminobenzidine and counterstain-
ing, etc., as above.
Fluorescent in situ hybridization for Cot-1
deoxyribonucleic acid
The mouse and human Cot-1 deoxyribonucleic acid
(DNA, Molecular Probes, Invitrogen, Glen Waverley, Aus-
tralia) were labeled with digoxigenin (DIG) using a DIG-
nick translation mix (Roche, Germany). Briefly, the standard
labeling reaction involved adding 1 mg of template DNA to
16 mL of sterile redistilled water and then adding 4 mL of
DIG-nick translation mix and incubating for 90min at 158C.
After the incubation, the reaction was placed on ice, and a
small sample was run on an agarose mini-gel along with
DNAmolecular weight markers to ensure that the probe was
between 200 and 500 nucleotides in length.When the correct
probe length was achieved, the reaction was stopped by add-
ing 1 mL 0.5M ethylenediaminetetraacetic acid (pH 8.0) and
heating to 658C for 10min. Sections were deparaffinized in
xylene for 10min, dehydrated, and air-dried. They were then
incubated in 1M sodium thiocyanate for 10min at 808C,
washed in PBS, and digested with proteinase K (20 mm/mL)
for 10min at 378C. After quenching in 0.2% glycine solu-
tion, they were washed in PBS, postfixed in 4% parafor-
maldehyde, dehydrated in graded alcohols, and air-dried.
DIG-labeled mouse or human Cot-1 DNA was then applied
to sections and sealed under glass coverslips. Simultaneous
denaturation was performed on a preheated hot plate set to
608C, followed by incubation overnight at 378C in a humid-
ified chamber. Slides were washed sequentially in 50% form-
amide /2standard saline citrate (SSC) for 35min each,
followed by 2SSC alone (35min each) and then 4SSC/
0.05% Tween 20 for 10min at 378C. Slides were then washed
in PBS, incubated in blocking solution for 30min, and incu-
bated sequentially in the following antibody solutions (all an-
tibodies at a concentration of 1:25) for 60min each at 378C
with 5-min washes in 0.2% Tween 20 in 1 PBS between
each incubation: anti-DIG monoclonal antibody, antimouse-
immunoglobulin-DIG, F(ab0)2-fragment, and anti-DIG-
fluorescein. Sections werewashedwith PBS and then distilled
water, counterstained using 4,6-diaminidino-2-phenylindone
(DAPI) at 40 ng/mL, and then mounted in Vectashield anti-
fade solution (Vector Laboratories, Burlingame, CA). The
slides were examined using a fluorescent microscope (Zeiss,
North Ryde, NSW, Australia). Positive signals for the Cot-1
DNA were identified as green dots within blue DAPI coun-
terstained nuclei.
RESULTS
Generation of adipose tissue
Matrigel/FGF2-only control chambers. The overall adi-
pogenic response in the control chambers containing FGF2-
supplemented GFR Matrigel but no inductive graft was
poor, consistent with previous findings.17 After 6 weeks of
incubation, isolated adipocytes and fibroblast-like cells were
seen scattered within the Matrigel, but few clusters of ad-
ipocytes were seen (Fig. 1A). The percentage of mature fat
cells calculated by point counting in the control chambers
averaged 17%. These adipocytes may have originated from
the remnants of the perivascular fat pad, having migrated
and differentiated within the Matrigel environment with
concomitant sprouting of neo-capillaries from the murine
vascular pedicle.
Matrigel/FGF2 chambers with human fat biopsies. Group
A (6 weeks) and B (9 weeks) chambers, which received a
human fat biopsy in addition to the FGF2-supplemented
Matrigel, both generated vascularized 3-D adipose tissue
constructs (Fig. 1B,C). The overall adipogenic response in
the biopsy-seeded chambers was better than that of the con-
trol chambers, with significant variation in adipogenic in-
duction between the engineered fat constructs ( p¼ .05), as
assessed using one-way analysis of variance with Dunnett’s
post hoc analysis. The average adipocyte counts were 30%
(6 weeks) (Fig. 1D) and 28% (9 weeks) (Fig. 1E).
In Group A, of the 13 total chambers established, 4 were
excluded because of infection (n¼ 2) and pedicle thrombo-
sis (n¼ 2), leaving 9 chambers for inclusion in the study.
Sprouting neo-capillaries seemed to direct specifically to-
ward the biopsy, particularly when the latter contained a
higher proportion of SVF to adipose tissue (Fig. 2A). The
degree of adipogenesis varied strongly throughout the cham-
bers, with adipogenic differentiation concentrated around
(neo-) capillaries (Fig. 2B). Two trends were apparent, al-
though neither was formally assessed. Human fat biopsies
containing a higher proportion SVF appeared to induce better
adipogenic responses than biopsies containingminimal SVF,
the latter inducing poor to moderate adipogenic responses,
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and there did not appear to be a direct correlation between
the size of the original human fat biopsies and the adipogenic
response.
In Group B, of the 8 chambers set up, one was excluded
because one of the wax plugs sealing the chamber had
become dislodged, and murine fat tissue clearly invaded the
chamber contents. The 7 remaining chambers were viable,
and all generated adipose tissue. Levels of adipogenesis
again varied between the chambers.
Chambers containing MA cultures (Group C). Angioge-
nesis was well developed throughout chambers containing
MA cultures. Numerous small vessels were clearly seen
sprouting from the pedicle along the periphery of the chamber,
FIG. 1. (A) Masson’s Trichrome–stained longitudinal section from a Matrigel-only control chamber. Only few scattered isolated ma-
ture adipocytes can be found in the predominantly Matrigel-filled chamber. (B) Macroscopic view of a fat construct harvested at 6 weeks
from a Matrigel/fibroblast growth factor (FGF)2–supplemented chamber. The original fat biopsy had been labeled with India ink before
implantation in the chamber. (C) Inferior view of the main host vascular pedicle with angiogenesis sprouting from the epigastric pedicle.
(D)Detailed viewof the surface of one of the generated fat constructs at 6weeks.Neo-capillaries are observed surroundingmature adipocytes
that is translated in the typical cobblestone appearance of fat tissue. Group A (6 weeks) (E) and B (9 weeks) (F) chambers, which received
a human fat biopsy in addition to the FGF2-supplemented Matrigel, both generated adipose tissue. The original fat graft adipocytes
degenerated into lipid cysts (gray arrow) and the stromal-vascular fraction is observed within the original fat xenograft (white arrow). Neo-
capillaries are seen penetrating the Matrigel environment (black arrow). Color images available online at www.liebertpub.com/ten.
FIG. 2. (A) Neo-capillaries directed specifically towards the stromal-vascular fraction of the fat biopsy. (B) A close association be-
tween developing adipocytes and sprouting young capillaries was observed in chambers generating adipose tissue. Color images avail-
able online at www.liebertpub.com/ten.
NEW FAT ORIGINATES FROM HOST RATHER THAN GRAFT IN MOUSE CHAMBER MODEL 2295
and new vessels and capillaries could be observed in most
parts of the chamber tissue. Approximately 25% of the
chambers were filled with small uni- and multilocular adi-
pocytes. The rest of the chamber contents included the orig-
inal pedicle, residual Matrigel-supporting elongated cells, the
original crude biopsies from the cultures, and a fibrous tissue
capsule.
Chambers containing SVF cultures (Group D). Tiny
vessels sprouting from the embedded pedicle were seen
macroscopically in chambers seeded with SVF cultures.
Histologically, numerous mature adipocytes were scattered
around the chambers, contributing 30% to 40% to the cham-
ber content. Multilocular adipocytes, elongated cells, blue-
staining collagen fibers, and multilayered capsule formation
were observed, as well as pedicle tissues and residual Ma-
trigel. However, chambers seeded with SVF cultures ap-
peared less vascularized than the MA-seeded chambers,
suggesting that the less-purified cultures of MA contained
higher levels of angiogenic factors.
Identification of the origin of the generated fat tissue:
vimentin immunolocalization
Biopsy chambers. Staining of the newly generated adi-
pocytes in the engineered constructs for the intermediate
filament protein vimentin using a human-specific antibody
was negative. However, vimentin expression was confirmed
in these cells with a mouse-specific antibody, and there
was prominent human vimentin labeling of the interstitial
fibroblast-like cells in the SVFof the xenografts (Fig. 3A, B).
MA/SVF chambers. Vimentin labeling was positive in the
human fibroblast-like cells of SVF culture chambers in vitro
when embedded in paraffin and sectioned, and some labeling
of mature adipocytes was also observed in the crude tissue
biopsies (Fig. 4). In contrast, there was no labeling of new
adipocytes within MA or SVF chambers, although some
fibroblast-like cells in the chambers labeled positive for vi-
mentin. Resting and migrating macrophages also labeled
positive for vimentin in some chambers, probably as a result
of digesting necrotic cells.
Cot-1 DNA labeling. Most of the generated adipose tis-
sue was strongly positive for the mouse-specific Cot-1
DNA using the fluorescent in situ hybridization technique,
whereas there was a distinct absence of any human Cot-1
DNA labeling, confirming the murine origin of the new
adipocytes (Fig. 5).
DISCUSSION
Cell transplantation techniques focus on direct injection
of cells or on placing them on biodegradable scaffolds before
implantation in vivo. In the field of adipose-tissue engineer-
ing, the purpose is to generate 3-D cultures on scaffolds
before implantation, but this technique has practical disad-
vantages because of diffusion limitations for cell survival.
Transplantation of cells must be augmented with methods to
ensure cell survival, such as the induction of an angiogenic
framework.18 In vivo cell recruitment (histioinduction) is one
of the techniques currently being explored at our institute to
engineer adipose tissue. This approach seems to be rational,
because it could induce concomitantly adipo- and angio-
genesis. The experimental in vivo model we are currently
using has the advantage that those 2 histiogenic processes
can be induced simultaneously. TheMatrigelmatrix supports
the interplay, or cross-talk, between developing adipocytes
and endothelial cells, which are not in direct apposition to
each other.
The studies described here confirm and extend our pre-
vious reports of the adipogenic potential of Matrigel in our
chambers.16,17 Sealed, Matrigel-filled chambers containing
excised syngeneic fat, cultured SVF cells, or 3-D explants of
cultured adipose biopsy produced 3-D vascularized tissue
constructs with a higher percentage of fat than the control
chambers with Matrigel alone. This is consistent with pre-
vious findings in C57bL/6 mice, in which access to pre-
existing tissue was essential for de novo adipogenesis in
FIG. 3. (A) Human-specific vimentin labeling shows positive fibroblast-like cells within the stromal-vascular compartment of the
original fat xenograft, suggesting survival of those cells, presumable preadipocytes (magnification20). (B) Detailed view of the cells
in the xenograft. Positive fibroblast-like cells are seen between degenerated adipocytes. Color images available online at www
.liebertpub.com/ten.
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the Matrigel/FGF2-filled chambers.16,17 Also, in studies in
which Matrigel induced fat in the subcutaneous space, ac-
cess to fat was constitutive, and the adipogenic precursors
were host derived.12,13,19 Labeling with human- and mouse-
specific probes for Cot-1 DNA and vimentin immunolabel-
ing confirmed the host derivation of the new adipose tissue,
indicating that the requirement for contact with adipose
tissue relates to inductive factors rather than the provision of
FIG. 4. Vimentin labeling of human stromal-vascular fraction (SVF) cultures in vitro and in vivo. (A) In vitro cells from SVF cultures
labeled strongly for vimentin. (B) Adipocytes arising within in vivo chambers implanted with these cultures were almost all negative.
(C) Fibroblastic cells in chambers implanted with SVF cultures, labeled for vimentin. (D) Migrating macrophages (arrows), which resembled
positive-staining fibroblastic cells, around a group of resting macrophages. Color images available online at www.liebertpub.com/ten.
FIG. 5. Most of the generated adipose tissue was strongly positive for mouse specific Cot-1 deoxyribonucleic acid (DNA) (A) using the
fluorescent in situ hybridization technique, whereas there was a distinct absence of any human Cot-1 DNA labeling, confirming the murine
origin of the new adipocytes. (B) 4,6-diaminidino-2-phenylindone counterstain (scale bar¼ 50 mm). Color images available online at
www.liebertpub.com/ten.
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precursor cells. Indeed, the likelihood that the cells that form
the new adipose tissue represent mesenchymal stem cells
(MSCs) is high, because these cells are pluripotent and can
generate adipose tissue with appropriate signals. The com-
bination of Matrigel, FGF2, and an inductive graft cause the
recruitment or differentiation of such host-derived precursor
cells.
Bone marrow is a rich source of circulating precursor
cells, including endothelial precursor cells and bone marrow
MSCss.20 Although bone marrow MSCs are a small constit-
uent of the bone marrow, chemokines released in response to
cells and tissue hypoxia can recruit them.20 Another potential
source of adipogenic precursor cells may be vascular peri-
cytes or host preadipocytes that may be present surrounding
the pedicle despite careful surgical stripping. This may ex-
plain the small amount of adipogenesis seen in the Matrigel-
only group. The smaller amounts of adipogenesis seen in
these chambers than in those containing grafts confirmed the
adipo-inductive effect of the graft. Recent studies,15,21 as
well as our own work (Ramakrishnan, Morrison et al., un-
published observation), show that adult adipose tissue also
houses MSCs with similar pluripotential characteristics. We
found that humanMSCs purified from human lipoaspirate or
bone marrow induced fat in SCID mouse chambers and that
this new fat was also of recipient origin, although the vas-
culature was of mixed recipient and human origin.
Thus, it is surprising that the biopsy-derived MSCs do
not contribute to the new adipose tissue, especially given
the apparent association between SVF and degree of adi-
pogenesis. One important caveat is a possible species mis-
match between an essential cytokine and receptor, such as
that known to exist for macrophage colony-stimulating fac-
tor receptor (c-fms) and colony stimulating factor-1, which
causes mouse colony stimulating factor-1 not to recognize
the human form of the c-fms receptor. Another caveat would
be an important role for the immune effector cells, which
are lacking in SCID mice, especially because these have
been implicated in adipogenesis. However, we recently per-
formed similar studies transplanting male biopsies into
female hosts, and vice-versa, in intact syngeneic mice, and
preliminary analysis reveals a similar scenario of host-
derived adipose tissue in response to an inductive graft
(Thomas et al., manuscript in preparation).
In considering the nature of the inductive factor(s), it is
noteworthy that we observed better adipose outcomes when
free-fat flaps containing a higher proportion of adipose
tissue were used. Biopsies containing more SVF also dem-
onstrated better cell survival in that compartment of the
graft, consistent with positive labeling for vimentin seen in
these regions of the biopsies. A common factor in the three
types of inductive sources used in all of these experiments
(graft, SVF culture, and MA culture) is the presence of a
SVF component. Cultured exogenous SVF/preadipocytes
have been used to induce fat subcutaneously, in conjunc-
tion with other scaffolds.13 Kimura et al. have reported that,
when collagen sponge seeded with human SVF was im-
planted subcutaneously into nudemice, they achieved human
adipose tissue, as indicated by vimentin immunolabeling.
These data contrast with our findings in the chamber envi-
ronment, which may be different because of the subcutane-
ous environment or the type of scaffold.
The in vitro cultures of SVF or MA in the chambers
induced different tissue morphologies than in chambers
seeded with a fat graft. These changes, which appear to in-
clude greater adipogenesis, may relate to the presence of
more SVF cells than in whole adipose biopsies. In vitro
culturing of SVF-residing cells with their intrinsic hetero-
geneity could also have upgraded them into a further stage
of more-mature cell development. These chambers also ap-
peared to show better qualitative vascularization than the
chambers containing fat biopsies. It may be that the addi-
tional cell fraction present encouraged a faster rate of an-
giogenesis, leading to a greater chance of cell survival.
Cellular structures resembling tubules were observed in the
chambers seeded with MA cultures, suggesting that ECM
components may have been modified in culture or that the
cells may secrete additional ECM components and that
these ECM components were able to act as inductive factors
to further enhance adipogenesis in vivo, similar to previous
in vitro studies.22 Prolonged in vitro culture of MA tissue
and cells could alter cell behavior, also affecting adipo-
genesis when seeded into chambers. The presence of growth
or differentiation factors secreted by the cultured cells may
be more important than the presence of the cells themselves.
Factors such as vitronectin23 and FGF2 that have roles in
regulating adipogenesis and angiogenesis could supple-
ment host-derived adipogenesis response to Matrigel. Fur-
ther studies will be undertaken to assess the potential
benefits of culturing autologous SVF for implantation.
Mature adipocytes introduced in all adipose biopsies de-
generated into cyst-like lipid deposits. Differences between
implanted biopsies, such as in the ratio of stromal tissue to
mature adipocytes appeared to affect the proportion of ad-
ipose tissue and other components in individual chambers.
Adipocytes and preadipocytes represent less than 50% of
the total cells in adipose tissue; the remaining cells include
stromal cells, blood cells, endothelial cells, and pericytes.
Some investigators have indicated that only 0.02% of the
SVF are preadipocytes capable of adipogenic differentia-
tion,24 with the rest of the population consisting of endo-
thelial cells and fibroblasts.
A strong relationship has been observed between angio-
genesis and adipogenesis in the chamber model.17 The fat
graft appeared to attract capillaries sprouting from the main
pedicle in the chambers, suggesting that biopsy-released
factors are initiating the neovascularization process, proba-
bly via hypoxia-induced factors.20 Hypoxia appears to
be an important regulator of adipocytes and endothelial
cells. Vascular endothelial growth factor, an important pro-
angiogenic factor, is released from endothelial cells during
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hypoxia and plays a role in signaling between endothelial
cells and preadipocytes.25 Such coordination between en-
dothelial cells and preadipocytes may maintain the adipose
precursor cell population in a nondifferentiated, ischemia-
tolerant state until sufficient vascularization has occurred.
The implantation of a whole tissue graft containing pre-
adipocytes and endothelial cells in the SVF has the advan-
tage of preserving the original cell structures, allowing for
the subsequent interplay between those different cell popu-
lations during the initial hypoxic period in the Matrigel-
filled tissue-engineering chamber. The SVF region in the
xenograft could function as a source of vasoactive signals
due to intercellular signaling processes between preadipo-
cytes, adipocytes, and endothelial cells. The surrounding
Matrigel environment may further enhance the response to
these signals due to selective binding of growth factors and
its action as a permissive substratum for recruited cells.
CONCLUSIONS
Our studies have considerable bearing on the growing
number of approaches to adipose engineering, such as use
of inductive fat with auto-grafted ‘‘preadipocytes’’ or pre-
adipocyte-conferring components such as processed lipo-
aspirate.6,15 These have traditionally been thought to
provide a source of new preadipocytes, which differentiate
into adipocytes, although our studies suggest otherwise. It
may also shed further light on the question of whether it is
graft survival, de novo adipogenesis, or a combination of
both that occurs during autologous fat transplantation, with
significance for our understanding of why such variable
results are obtained with this widely used technique. In
conclusion, we have produced 3-D vascularized adipose
constructs using crude adipose biopsies or stromal-vascular
cell cultures. Species-specific labeling indicates that the
new tissue is of host origin, rather than from the donor
explants. The host origin of the newly derived adipogenesis
suggests that the explants are acting in an inductive capac-
ity, rather than as a source of exogenous precursor cells for
the new tissue. These findings will be important in determin-
ing the optimum conditions for the development of de novo
fat tissues for tissue engineering.
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